2279 related articles for article (PubMed ID: 32785815)
61. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.
Usmani SS; Raghava GPS
Front Immunol; 2020; 11():561851. PubMed ID: 33133071
[No Abstract] [Full Text] [Related]
62. DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
Yu J; Tostanoski LH; Peter L; Mercado NB; McMahan K; Mahrokhian SH; Nkolola JP; Liu J; Li Z; Chandrashekar A; Martinez DR; Loos C; Atyeo C; Fischinger S; Burke JS; Slein MD; Chen Y; Zuiani A; Lelis FJN; Travers M; Habibi S; Pessaint L; Van Ry A; Blade K; Brown R; Cook A; Finneyfrock B; Dodson A; Teow E; Velasco J; Zahn R; Wegmann F; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kirilova M; Kordana N; Lin Z; Maxfield LF; Nampanya F; Nityanandam R; Ventura JD; Wan H; Cai Y; Chen B; Schmidt AG; Wesemann DR; Baric RS; Alter G; Andersen H; Lewis MG; Barouch DH
Science; 2020 Aug; 369(6505):806-811. PubMed ID: 32434945
[TBL] [Abstract][Full Text] [Related]
63. Are asylum seekers, refugees and foreign migrants considered in the COVID-19 vaccine discourse?
Mukumbang FC
BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33177039
[No Abstract] [Full Text] [Related]
64. Demystifying BCG Vaccine and COVID-19 Relationship.
Kumar J; Meena J
Indian Pediatr; 2020 Jun; 57(6):588-589. PubMed ID: 32358227
[No Abstract] [Full Text] [Related]
65. Russian SARS-CoV-2 vaccine.
Caddy S
BMJ; 2020 Aug; 370():m3270. PubMed ID: 32839191
[No Abstract] [Full Text] [Related]
66. Attitudes of Healthcare Personnel towards Vaccinations before and during the COVID-19 Pandemic.
Ledda C; Costantino C; Cuccia M; Maltezou HC; Rapisarda V
Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33800187
[TBL] [Abstract][Full Text] [Related]
67. Development of an inactivated vaccine candidate for SARS-CoV-2.
Gao Q; Bao L; Mao H; Wang L; Xu K; Yang M; Li Y; Zhu L; Wang N; Lv Z; Gao H; Ge X; Kan B; Hu Y; Liu J; Cai F; Jiang D; Yin Y; Qin C; Li J; Gong X; Lou X; Shi W; Wu D; Zhang H; Zhu L; Deng W; Li Y; Lu J; Li C; Wang X; Yin W; Zhang Y; Qin C
Science; 2020 Jul; 369(6499):77-81. PubMed ID: 32376603
[TBL] [Abstract][Full Text] [Related]
68. Preparing for the vaccine.
Nat Biotechnol; 2020 Nov; 38(11):1219. PubMed ID: 33110209
[TBL] [Abstract][Full Text] [Related]
69. COVID-19 disrupts vaccine delivery.
Nelson R
Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
[No Abstract] [Full Text] [Related]
70. Preparing the public for COVID-19 vaccines: How can general practitioners build vaccine confidence and optimise uptake for themselves and their patients?
Danchin M; Biezen R; Manski-Nankervis JA; Kaufman J; Leask J
Aust J Gen Pract; 2020 Oct; 49(10):625-629. PubMed ID: 33015676
[TBL] [Abstract][Full Text] [Related]
71. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
Wang EA; Zenilman J; Brinkley-Rubinstein L
JAMA; 2020 Sep; 324(11):1031-1032. PubMed ID: 32808972
[No Abstract] [Full Text] [Related]
72. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
73. Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot.
Rubin EJ; Baden LR; Piot P; Morrissey S
N Engl J Med; 2020 Jul; 383(5):e57. PubMed ID: 32726549
[No Abstract] [Full Text] [Related]
74. A Cross-Sectional Survey on COVID-19 Vaccine Hesitancy Among Parents From Shandong vs. Zhejiang.
Xu Y; Xu D; Luo L; Ma F; Wang P; Li H; Li Q; Wei L; Diao J; Liu Y; Zhang W; Zheng X
Front Public Health; 2021; 9():779720. PubMed ID: 34805084
[No Abstract] [Full Text] [Related]
75. Talk to Patients About: Why Will It Take So Long for a COVID-19 Vaccine?
Price S
Tex Med; 2020 Jun; 116(6):19. PubMed ID: 32645183
[TBL] [Abstract][Full Text] [Related]
76. Will healthcare workers improve infection prevention and control behaviors as COVID-19 risk emerges and increases, in China?
Lai X; Wang X; Yang Q; Xu X; Tang Y; Liu C; Tan L; Lai R; Wang H; Zhang X; Zhou Q; Chen H
Antimicrob Resist Infect Control; 2020 Jun; 9(1):83. PubMed ID: 32527300
[TBL] [Abstract][Full Text] [Related]
77. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
[TBL] [Abstract][Full Text] [Related]
78. Audio Interview: Covid-19 Vaccine Development.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Jul; 383(3):e40. PubMed ID: 32668131
[No Abstract] [Full Text] [Related]
79. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.
Wang H; Zhang Y; Huang B; Deng W; Quan Y; Wang W; Xu W; Zhao Y; Li N; Zhang J; Liang H; Bao L; Xu Y; Ding L; Zhou W; Gao H; Liu J; Niu P; Zhao L; Zhen W; Fu H; Yu S; Zhang Z; Xu G; Li C; Lou Z; Xu M; Qin C; Wu G; Gao GF; Tan W; Yang X
Cell; 2020 Aug; 182(3):713-721.e9. PubMed ID: 32778225
[TBL] [Abstract][Full Text] [Related]
80. Rapid COVID-19 vaccine development.
Graham BS
Science; 2020 May; 368(6494):945-946. PubMed ID: 32385100
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
